Deadline: 31 July 2024
The Association Galien Africa in partnership with the Galien Foundation, has launched a call for applications for the 4th edition of the “Prix Galien Africa” which rewards excellence and innovation.
It aims to reward researchers, institutions and pharmaceutical industries from the public or private sector that have successfully developed initiatives, services, pharmaceutical, biotechnological, phytotherapy, diagnostic products and medical devices recently introduced on the African market. The “Prix Galien Africa” rewards pharmaceutical and phytotherapy sciences that improve the human condition, mainly on the basis of the following criteria:
- Innovation and/or discovery
- Impact on the African continent.
- Collaboration with an African institution for products presented by non-African institutions
Categories
- The prize categories to be awarded are:
- the best pharmaceutical product,
- the best traditherapy product,
- the best biotechnology product,
- the best medical technology or digital solution (medical device, diagnostic, e-health, telemedicine, patient records, etc.)
Funding Information
- Each prize is endowed with a 20,000,000 FCFA (Twenty Million Cfa Francs) grant, or about 30,000 USD (Thirty Thousand US Dollars).
Eligibility Criteria
- The “Prix Galien Africa” is open to researchers, institutions and pharmaceutical industries from the public or private sector, having developed pharmaceutical, biotechnological, phytotherapy, diagnostic products and medical devices, marketed in the African countries and having obtained the mar keting authorization (MA), delivered by at least one African pharmaceutical regulatory authority.
- Pharmaceutical, biotechnological, herbal medicine, diagnostic and medical devices must be based on innovative science, developed by synthetic chemistry or molecular biology or manufactured naturally with plants according to precise criteria, specifications, tested in controlled clinical trials and marketed by ethical pharmaceutical companies.
- The initial marketing authorization must be valid for a maximum of five years as of December 31 of the competition year. Exemptions could be granted for digital technology or solutions and for Traditional therapy products. As the MA is not applicable to digital technology or solutions and Traditional therapy, the selection criteria are defined by an assessment grid drawn up by the Jury.
For more information, visit Prix Galien Africa.